TROKENDI XR 50 MG CAPSULE

topiramate
$15.3195per EA

Strength

50 mg/1

NDC

17772010201

Classification

Brand

Dosage Form

CAPSULE, EXTENDED RELEASE

Route

ORAL

Last Updated

10/23/2024

Active Ingredients

TOPIRAMATE

Approval Type

New Drug (NDA)

FDA Application

NDA201635

On Market Since

8/16/2013

Pharmacological Classes

Cytochrome P450 2C19 Inhibitors
Cytochrome P450 3A4 Inducers
Decreased Central Nervous System Disorganized Electrical Activity

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

-0.2%

5Y

+12.2%

All

+110.5%